BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TCP Reliable Announces Their Initiative To Bring ATP Products Into The US


4/30/2010 1:36:48 PM

TCP Reliable signed a multi-year commercial agreement with Canadian based company, ATP to sell and market their products in the US.

In turn, TCP has announced the creation of a new business unit dedicated to provide regulatory and cold chain compliance products to the US market. To launch this initiative, John Hart has been appointed Chief Technology Officer.

"Beginning in May of this year, TCP will be making a huge marketing effort to introduce these products and services to the rapidly expanding US market," Hart said.

TCP sees a huge market for ATP's computerized solutions including; ATP-ThermoProfile™, an innovative and cost effective software platform for data loggers, ATP-Mirador™, for real time monitoring of temperature controlled products, and ATP-DOCOS™, a document management software used in regulatory compliance applications.

"Our goal is to give our current pharmaceutical customers easy access to the tools required to help them control their supply chain processes" Hart said. "The role of ATP will be to help them implement cold chain quality compliance solutions best suited to their needs."

The first phase for many customers will be to perform a Gap Analysis. This procedure allows the customers to better understand the "gaps" or areas for improvement within their cold chain processes."With TCP as a strategic partner, we will be able to provide a more complete cold chain expertise to fulfill the needs of the North American Life sciences industry," Mr. Jean Bedard, CEO of ATP said.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES